G/LIC/N/2/PHL/2  
 
9 November  2016 
(16-6131) Page: 1/3 
Committee on Import Licensing  Original: English  
 
 AGREEMENT ON IMPORT LICENSING PROCEDURES  
NOTIFICATION UNDER A RTICLE 5.1 -5.4 OF THE AGREEMENT1 
PHILIPPINES  
The following notification, dated 3 November 2016  is being circulated at the request of the 
delegation of the Philippines . 
 
1. (a) Title / number / d ate of the law or regulation establishing / changing the 
import licensing procedure:   
• Republic Act (R.A.) No. 9165 (The Comprehensive Dangerous Drugs Act of 
2002) dated 7 June 2002  
• Dangerous Drugs Board Regulation No.1 Series 2014 “Comprehensive 
Amend ments to Board Regulation No. 3 Series 2003, "Comprehensive Guidelines 
on Importation, Distribution, Manufacture, Prescription, Dispensing and Sale of, 
and Other Lawful Acts in Connection with Any Dangerous Drugs, Controlled 
Precursors and Essential Chemic als and Other Similar or Analogous Substances", 
as Amended, and Other Related Board Issuances.  
• Dangerous Drugs Board Regulation No.1 Series 2015. Inclusion of Alpha -
Phenylacetoacetonitrile (“APAAN”) In the list of controlled precursors and essential 
chem icals. 
• Dangerous Drugs Board Regulation No.2 Series 2015. Inclusion of 1, 2 -
Dimethyl -3-Phenyl Aziridine and its cis and trans isomers in the list of controlled 
precursors and essential chemicals.  
• Dangerous Drugs Board Regulation No.3 Series 2015. Inclu sion of salvia 
divinorum, its resin, extract, tinctures or other forms and / or any part or portion 
thereof in the list of dangerous drugs.  
 (b) If the notified measure refers to a change in an already notified import 
licensing procedure, please indicate t he document symbol of the 
notification to which change(s) has(ve) been introduced. (In this case 
please also indicate in Section 3, below, the nature of the changes (i.e. inclusion 
or exclusion of some goods and a list thereof; contact point for informatio n and/or 
administrative body(ies) for submission of applications, etc.)):    
2. Information  concerning the institution / change of import licensing procedure:  
(a) List of products subject to the licensing procedure  (Exact name of the 
products and/or whenev er possible HS code and indication of the exact HS 
Nomenclature (i.e.  1996; 2002 or 2007).  Abbreviations should be avoided.  In 
the case of a long list of products, please attach the list as an Annex in Microsoft 
Word or compatible software.  Please do n ot use PDF, or photocopies. )  
• Substances listed in the schedules annexed to the 1961 Single Convention on 
Narcotic Drugs, as amended by the 1972 Protocol, and in the schedules annexed 
to the 1971 Single Convention on Psychotropic Substances as enumerated  in the 
annex of R .A. 9165. All regulatory control measures apply.  G/LIC/N/2/PHL/2  
 
- 2 - 
 
  • Substances listed in Tables I and II of the 1988 UN Convention Against Illicit 
Traffic in Narcotic Drugs and Psychotropic Substances as enumerated in the 
Annex of R .A. 9165 pursuant to Se ction 93 Article XI of R .A. 9165 for domestic 
control. All regulatory control measures apply.  
• Substances included as dangerous drugs by the Dangerous Drugs Board 
pursuant to Section 93 Article XI of R .A. 9165 for domestic control [Ephedrine, 
Pseudoephedr ine, Ketamine, Oripavine, Amineptine, N -Benzylpiperazine (BZP), 
Nalbuphine Hydrochloride, Methylephedrine, Salvia Divinorium]. All regulatory 
control measures apply.  
• Substances included as controlled chemical by the Dangerous Drugs Board 
pursuant to Sect ion 93 Article XI of R .A. 9165 for domestic control [Thionyl 
Chloride, Alpha -Phenylacetoacetonitrile (“APAAN”), 1, 2 -Dimethyl -3-Phenyl 
Aziridine,]. All regulatory control measures apply.  
• Mixtures/preparations/products containing controlled chemicals and reagents, 
analytical standards, etc.  Containing dangerous drugs with specific prescribed 
regulatory control measures as provided under Section 4 of Board Regulation 
No. 1, Series 2014 [see attached Tables I and II].  
(b) Contact point for information on el igibility   
Philippine Drug Enforcement Agency  (PDEA)   
Compliance Service  
PDEA Bldg., NIA Northside Road, National Government Center, Brgy. Pinyahan, 
Quezon City, Metro Manila  
Telephone:  (02) 927 -9702 Local 197/198   
Fax: (02) 920 -8110  
E-mail address:  feocsg@pnp.gov.ph   
Website:   
Contact officer:  [   ] Mr. [   ] Mrs. Name:  [          ]  
(c) Administrative body(ies) for submission of applications  (If more than one 
please include the same information for each body. ) 
Philippine Drug enforcement Agency (PDEA)  
Compliance Service  
PDEA Bldg., NIA Northside Road, National Government Center, Brgy. Pinyahan, 
Quezon City, Metro Manila  
Telephone:  (02) 927 -9702 Local 197/198  
Fax: (02) 920 -8110 
E-mail address:  www.cs@pdea.gov .ph 
Website:   
Contact officer:  [   ] Mr. [   ] Mrs. Name:  [          ]  
(d) Date and name of publication where licensing procedures are published  
Date of publication:   
Source of publication (Official Gazette /journal/ website):   
http://www.ddb.gov.ph/   
http://pdea.gov.ph/   
(e) Indication of whether the licensing procedure is   
[   ] automatic.  If so please indicate: (f) the administrative purpose: []  
[X] non-automatic.   If so please indicate:  (g) the measure being 
implemented through the import licensing procedure:   
This is in compliance with the International Drug Control Conventions  where the  
Philippines is a signatory.  The Philippine Drug Enforcement Agency (PDEA) , 
control and regulates the legitimate use of all s ubstances internationally and 
locally classified as dangerous drugs and controlled precursors and essential 
chemicals, thus entities who wish to import, distribute, manufacture, prescribe 
and dispense such subs tances  are required to secure appropriate license and G/LIC/N/2/PHL/2  
 
- 3 - 
 
  permit to Philippine Drug Enforcement Agency (PDEA), Compliance Service prior 
to import/usage . 
(h) Expected duration of the licensing procedure if this can be estimated with 
some probability, and if not , reason why this information cannot be 
provided  
• License to import controlled substances is approved and released within the 
day of application upon receipt of application with complete requirements.  
• New application of license to import controlled substan ces is subject to Physical 
Security Inspection. After Inspection of a qualified entity, license is issued 
within the day of application with complete requirements.  
• Permit to import controlled substances is approved and released within fifteen 
(15) working days upon receipt of application with complete requirements and 
appropriate and valid PDEA License.  
3. Other relevant data or information:  (i.e. complete title and data concerning the 
legislation, inclusion or exclusion of certain products from the import  licensing regime and 
list thereof; changes related to t he administrative body(ies) for submission of 
applications, etc. ) 
 Dangerous Drugs Board Regulation No.1 Series 2014  “Comprehensive 
Amendments to Board Regulation No. 3 Series 2003, "Comprehensive Guid elines on 
Importation, Distribution, Manufacture, Prescription, Dispensing and Sale of, and Other 
Lawful Acts in Connection with Any Dangerous Drugs, Controlled Precursors and 
Essential Chemicals and Other Similar or Analogous Substances", as Amended, and 
Other Related Board Issuances.  
 Dangerous Drugs Board Regulation No.1 Series 2015. Inclusion of Alpha -
Phenylacetoacetonitrile(“APAAN”) In the list of controlled precursors and essential 
chemicals.  
 Dangerous Drugs Board Regulation No.2 Series 2015.  Inclusion  of 1, 2 -Dimethyl -
3-Phenyl Aziridine and its cis and trans isomers in the list of controlled precursors and 
essential chemicals.  
 Dangerous Drugs Board Regulation No.3 Series 2015 . Inclusion of salvi a 
divinorum, its resin, extract, tinctures or other forms and / or any part or portion 
thereof in the list of dangerous drugs.  
All substances listed in the above regulations, are required to secure appropriate 
license and permit to Philippine Drug Enforcem ent Agency  (PDEA) , Compliance 
Service  prior to import/usage.  
 
 
 
__________  
 
 
                                                
1 "Members which institute licensing procedures or changes in these procedures shall notify the 
Committee of such within 60 days of publication [...]" (Ar t. 5.1) .